1. Sucralfate Protects Intestinal Epithelial Cells from Radiation-Induced Apoptosis in Rats
- Author
-
Kumio Okaichi, Masahiro Nakashima, Kazuko Shichijo, Ichiro Sekine, Mutsumi Matsuu-Matsuyama, Kouji Ishii, Yutaka Okumura, Chung Yang Wen, Toshiyuki Nakayama, and Eiichiro Fukuda
- Subjects
Male ,p53 ,medicine.medical_specialty ,Sucralfate ,Health, Toxicology and Mutagenesis ,medicine.medical_treatment ,Crypt ,Epithelial Stem Cell ,Apoptosis ,Radiation-Protective Agents ,Radiation-induced apoptosis ,Gastroenterology ,Internal medicine ,medicine ,Animals ,Radiology, Nuclear Medicine and imaging ,Intestinal Mucosa ,Rats, Wistar ,Radiation Injuries ,Cells, Cultured ,Radiation ,Radiation induced apoptosis ,Arc (protein) ,Chemistry ,Epithelial Cells ,digestive system diseases ,Rats ,Intestine ,Radiation therapy ,Treatment Outcome ,Acute radiation colitis ,Cancer research ,Whole-Body Irradiation ,medicine.drug - Abstract
Radiotherapy for malignant pelvic disease is often followed by acute radiation colitis (ARC). It has been reported that sucralfate treatment has a protective effect against ARC, though the mechanisms of action are unknown. The effects of sucralfate on X-ray radiation-induced apoptosis was studied at 4 Gy in the colonic crypt cells of rats. Sucralfate enemas given prior to radiation resulted in the following: (1) reduction in number of apoptotic colonic crypt cells; (2) reduction in number of caspase-3 positive cells; (3) decreases in p53 accumulation and p21 expression; (4) decreases of Bax/Bcl-2 ratio. The protective effects of sucralfate against ARC may be partially due to the suppression of radiation-induced apoptosis by way of p53 in the colon and the protection of the colonic epithelial stem cell region., Journal of radiation research. 2006, 47(1), p.1-8
- Published
- 2006